
HC Wainwright & Co. maintains Adocia (OTC:ADOCY) with a Buy and lowers the price target from $21 to $19.
You can purchase shares of ADOCIA S/ADR by Adocia ACT (OTCEM:ADOCY) through any online brokerage.
There are no as such competitors for ADOCIA S/ADR by Adocia ACT.
There is no analysis for ADOCIA S/ADR by Adocia ACT to provide a consensus price target.
The stock price for ADOCIA S/ADR by Adocia ACT (OTCEM: ADOCY) is $ last updated December 31, 1969 at 7:00 PM EST.
There are no upcoming dividends for ADOCIA S/ADR by Adocia ACT.
ADOCIA S/ADR by Adocia ACT does not have any upcoming earnings scheduled.
There is no upcoming split for ADOCIA S/ADR by Adocia ACT.
ADOCIA S/ADR by Adocia ACT is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Adocia is a clinical-stage biotechnology company focused on developing treatments for diabetes, obesity, and related metabolic diseases. The company uses its proprietary BioChaperone, AdoShell, AdOral and AdoXLong technology platforms to develop...